Application of a Statistical Method to the Absorption of a New Model Drug from Micellar and Lipid Formulations—Evaluation of Qualitative Excipient Effects

REFERENCES

• Robinson J.R. Introduction: Semi-solid formulations for oral drug delivery. Bulletin Technique Gattefossé 1996; 11–13
   Google Scholar
• Strickley R.G. Solubilizing excipients in oral and injectable formulations. Pharm. Res. 2004; 21(2)201–230
   PubMed Web of Science ®Google Scholar
• Humberstone A.J., Charman W.N. Lipid based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 1997; 25: 103–128
   Web of Science ®Google Scholar
• Charman W. Lipids, lipophilic drugs, and oral drug delivery—Some emerging concepts. J. Pharm. Sci. 2000; 89(8)967–978
   PubMed Web of Science ®Google Scholar
• Pouton C.W. Key issues when formulating hydrophobic drugs with lipids. Bulletin Technique Gattefossé 1999; 41–49
   Google Scholar
• Pouton C.W. Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying, and “self-microemulsifying” drug delivery systems. Eur. J. Pharm. Sci. 2000; 11(Suppl. 2)S93–S98
   PubMed Web of Science ®Google Scholar
• Gershanik T., Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Europ. J. Pharm. Biopharm. 2000; 50: 179–188
   PubMed Web of Science ®Google Scholar
• Gursoy R.N., Benita S. Self-emulsifying drug delivery sytems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004; 58: 173–182
   PubMed Web of Science ®Google Scholar
• Lawrence M.J., Rees G.D. Microemulsion based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 2000; 45: 89–121
   PubMed Web of Science ®Google Scholar
• Porter C.J.H., Kaukonen A.M., Boyd B.J., Edwards G.A., Charman W. Susceptibility to lipase mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid based microemulsion formulation. Pharm. Res. 2004; 21(8)1405–1412
   PubMed Web of Science ®Google Scholar
• Pouton C.W. Formulation of poorly water-soluble drugs for oral administration. Bulletin Technique Gattefossé 2005; 39–51
   Google Scholar
• Ritschel W.A. Gastrointestinal absorption of peptides using microemulsions as delivery systems. Bulletin Technique Gattefossé 1990; 7–22
   Google Scholar
• De Smidt P.C., Campanero M.A., Trocóniz I.F. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int. J. Pharm. 2004; 270: 109–118
   PubMed Web of Science ®Google Scholar
• MacGregor K.J., Embleton J.K., Lacy J.E., Perry E.A., Solomon L.J., Seager H., Pouton C.W. Influence of lipolysis on drug absorption from the gastro intestinal tract. Adv. Drug Deliv. Rev. 1997; 25: 33–46
   Web of Science ®Google Scholar
• Shen H., Howles P., Tso P. From the interaction of lipid vesicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons. Adv. Drug Deliv. Rev. 2001; 50: S103–S125
   PubMed Web of Science ®Google Scholar
• O'Driscoll C.M. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 2002; 15: 405–415
   PubMed Web of Science ®Google Scholar
• Charman W.N., Porter C.J.H., Mithani S., Dressman J. Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH. J. Pharm. Sci. 1997; 86(3)269–282
   PubMed Web of Science ®Google Scholar
• Hunt J.N., Knox M.T. Control of gastric emptying. Am. J. Dig. Dis. 1968; 13: 372–375
   PubMedGoogle Scholar
• Hunt J.N., Knox M.T. A relation between the chain length of fatty acids and and the slowing of gastric emptying. J. Physiol. (London) 1968; 194: 327–336
   Google Scholar
• Ch Porter, Charman N. Lipid-based formulations for oral administration: opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs. J. Recept. Signal Transduct. Rese. 2001; 21(2&3)215–257
   PubMedGoogle Scholar
• Wacher V.J., Salphati L., Benet L.Z. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug. Del. Rev. 2001; 46: 89–102
   PubMed Web of Science ®Google Scholar
• Gao P., Rush B.D., Pfund W.P., Huang T., Bauer J.M., Morozowich W., Kuo M.S., Hageman M.J. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with Improved oral bioavailability. J. Pharm. Sci. 2003; 92(12)2386–2398
   PubMed Web of Science ®Google Scholar
• Hutchinson K. Digestible emulsions and microemulsions for optimum oral delivery of hydrophobic drugs. Bulletin Technique Gattefossé 1994; 67–74
   Google Scholar
• Chiu Y.Y., Higaki K., Neudeck B.L., Barnett J.L., Welage L.S., Amidon G.L. Human jejunal permeability of cyclosporine A: Influence of surfactants on P-glycoprotein efflux in Caco 2 cells. Pharm. Res. 2003; 20(5)749–756
   PubMed Web of Science ®Google Scholar
• Yu L., Bridgers A., Polli J., Vickers A., Long S., Roy A., Winnike R., Coffin M. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm. Res. 1999; 16(12)1812–1817
   PubMed Web of Science ®Google Scholar
• Gershanik T., Benzeno S., Benita S. Interaction of a self-emulsifying lipid delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge. Pharm. Res. 1998; 15(6)863–869
   PubMed Web of Science ®Google Scholar
• Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 2000; 89(4)429–442
   PubMed Web of Science ®Google Scholar
• Sharma P., Chawla H.P.S., Panchagnula R. The role of sorption promoters in increasing the bioavailability of drugs in oral preparations. Drugs Future 1999; 24(11)1221–1240
   Google Scholar
• Seeballuck F., Ashford M.B., O'Driscoll C.M. The effect of pluronic block copolymers and cremophor EL on intestinal lipoprotein processing and the potential link with P-glykoprotein in Caco-2 cells. Pharm. Res. 2003; 20(7)1085–1092
   PubMed Web of Science ®Google Scholar
• Dahan A., Hoffmann A. Evaluation of chylomicron flow blocking approach to investigate the lymphatic transport of lipophilic drugs. Eur. J. Pharm. Sci. 2005; 24: 381–388
   PubMed Web of Science ®Google Scholar
• Porter C.J.H., Charman W.N. In vitro assessment of oral lipid based formulations. Adv. Drug Deliv. Rev. 2001; 50: S127–S147
   PubMed Web of Science ®Google Scholar
• Gabrielsson J., Lindberg N.O., Lundstedt T. Multivariate methods in pharmaceutical applications. J. Chemometr. 2002; 16: 141–160
   Web of Science ®Google Scholar
• Gabrielsson J., Lindberg N.O., Pålsson M., Nickolasson F., Sjöström M., Lundstedt T. Multivariate methods in the development of a new tablet formulation. Drug. Dev. Ind. Pharm. 2003; 29(10)1053–1075
   PubMed Web of Science ®Google Scholar
• Odeberg J.M., Kaufmann P., Kroon K.G., Höglund P. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur. J. Pharm. Sci. 2003; 20: 375–382
   PubMed Web of Science ®Google Scholar
• Erikksson L, Johansson E, and Kettaneh-Wold, Wold S. Multi- and Megavariate Data Analysis. Principles and Applications. Umetics AB, Sweden 2001; 71–77
   Google Scholar
• Erikksson L, Johansson E, Wold Kettaneh-, Wold S. Multi- and Megavariate Data Analysis. Principles and Applications. Umetics AB, Sweden 2001; 105
   Google Scholar
• Huberstone A.J., Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Delive. Rev. 1997; 25: 103–128
   Web of Science ®Google Scholar
• Grove M, Pedersen G.P., Nielsen J.L., Müllertz A. Bioavailability of seocalcitol I. Relating solubility in biorelevant media with oral bioavailability in rats—Effect of medium and long chain triglycerides. J. Pharm. Sci. 2005; 94(8)1830–1838
   PubMed Web of Science ®Google Scholar